glp 1 and ms Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism The Interplay Between GLP-1-Based Therapies,

Vascular Effects Vascular effects include: Angiogenesis Promotion Through VEGF and bFGF expression at 1 nM concentration Improved Blood Vessel Integrity Through collagen and elastin synthesis in vessel walls SPARC Protein Release Released during injury stimulates vessel growth and repair Enhanced Microcirculation Improved blood flow to peripheral tissues Anticoagulation Properties Demonstrated effects on blood clotting factors Restored Blood Flow To damaged tissues enhancing healing capacity Injectable Dosing Protocols and Administration Injectable GHK-Cu protocols typically use carefully calibrated dosing based on decades of research and clinical experience

Nobody really wants to start a patient on a drug that isn't clinically indicated

Bioorg Med Chem 2002

And you deserve to finally feel better

A peptide is a small protein

Abstract Background Glucagon-like peptide 1 receptor agonists (GLP1RAs) are used in the treatment of diabetes and obesity